Shagun Singh Chadha
Stock Analyst at RBC Capital
(0.86)
# 3,866
Out of 4,486 analysts
642
Total ratings
45.1%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by Shagun Singh Chadha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $100 | $94.82 | +5.46% | 52 | Jun 29, 2026 | |
| GEHC GE HealthCare Technologies | Initiated Coverage: Buy | $80 | $64.89 | +23.29% | 1 | Jun 23, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $318.31 | +17.50% | 38 | Jun 11, 2026 | |
| MDT Medtronic | Reiterated: Buy | $118 | $83.83 | +40.76% | 46 | Jun 3, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $100 | $45.30 | +120.75% | 56 | May 27, 2026 | |
| PODD Insulet | Maintained: Buy | $280 | $161.55 | +73.32% | 17 | May 27, 2026 | |
| DXCM DexCom | Reiterated: Buy | $85 | $73.57 | +15.54% | 27 | May 15, 2026 | |
| TFX Teleflex | Upgraded: Buy | $135 → $155 | $133.54 | +16.07% | 50 | May 8, 2026 | |
| OM Outset Medical | Reiterated: Hold | $7 | $4.81 | +45.68% | 39 | May 8, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Hold | $175 | $156.30 | +11.96% | 11 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $120 | $78.83 | +52.23% | 39 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $15.43 | +94.43% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 → $45 | $50.08 | -10.14% | 27 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $435 | $329.74 | +31.92% | 46 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $89.41 | +12.96% | 40 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $427.30 | +52.12% | 46 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $130 | $95.84 | +35.64% | 42 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $265 | $267.24 | -0.84% | 45 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $17.46 | n/a | 1 | Apr 29, 2021 |
Edwards Lifesciences
Jun 29, 2026
Reiterated: Buy
Price Target: $100
Current: $94.82
Upside: +5.46%
GE HealthCare Technologies
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $64.89
Upside: +23.29%
Penumbra
Jun 11, 2026
Maintained: Hold
Price Target: $374
Current: $318.31
Upside: +17.50%
Medtronic
Jun 3, 2026
Reiterated: Buy
Price Target: $118
Current: $83.83
Upside: +40.76%
Boston Scientific
May 27, 2026
Maintained: Buy
Price Target: $100
Current: $45.30
Upside: +120.75%
Insulet
May 27, 2026
Maintained: Buy
Price Target: $280
Current: $161.55
Upside: +73.32%
DexCom
May 15, 2026
Reiterated: Buy
Price Target: $85
Current: $73.57
Upside: +15.54%
Teleflex
May 8, 2026
Upgraded: Buy
Price Target: $135 → $155
Current: $133.54
Upside: +16.07%
Outset Medical
May 8, 2026
Reiterated: Hold
Price Target: $7
Current: $4.81
Upside: +45.68%
Becton, Dickinson and Company
May 7, 2026
Maintained: Hold
Price Target: $175
Current: $156.30
Upside: +11.96%
May 7, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $78.83
Upside: +52.23%
May 7, 2026
Maintained: Buy
Price Target: $30
Current: $15.43
Upside: +94.43%
May 4, 2026
Reiterated: Hold
Price Target: $56 → $45
Current: $50.08
Upside: -10.14%
May 1, 2026
Reiterated: Buy
Price Target: $435
Current: $329.74
Upside: +31.92%
Apr 28, 2026
Maintained: Buy
Price Target: $101
Current: $89.41
Upside: +12.96%
Apr 21, 2026
Reiterated: Buy
Price Target: $650
Current: $427.30
Upside: +52.12%
Apr 16, 2026
Reiterated: Buy
Price Target: $135 → $130
Current: $95.84
Upside: +35.64%
Apr 14, 2026
Maintained: Buy
Price Target: $255 → $265
Current: $267.24
Upside: -0.84%
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $17.46
Upside: n/a